<html>
<head>
<title>Section 132:30 Maternal Mortality Review Panel Established.</title>
<!-- Hide metadata
<titlename>TITLE X PUBLIC HEALTH</titlename>
<chapter>CHAPTER 132 PROTECTION FOR MATERNITY AND INFANCY</chapter>
<sectiontitle>Section 132:30 Maternal Mortality Review Panel Established.</sectiontitle>
-->
<meta name="titlename" content="TITLE X PUBLIC HEALTH">
<meta name="chapter" content="CHAPTER 132 PROTECTION FOR MATERNITY AND INFANCY">
<meta name="sectiontitle" content="Section 132:30 Maternal Mortality Review Panel Established.">
<meta name="sourcenote" content="Source.  2010, 129:2, eff. Aug. 8, 2010.">
<meta name="codesect" content="<br>&nbsp&nbsp&nbspI. There is established a maternal mortality review panel to conduct comprehensive, multidisciplinary reviews of maternal deaths in New Hampshire for the purpose of identifying factors associated with the deaths and to make recommendations for system changes to improve services for women in the state.  The panel shall consist of:<br>&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp(a) Two members from the New Hampshire chapter of the American College of Obstetricians and Gynecologists, one of whom shall be a generalist obstetrician, and one of whom shall be a maternal fetal medicine specialist.<br>&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp(b) One member from the New Hampshire chapter of the American Academy of Pediatrics, specializing in neonatology.<br>&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp(c) One member from the New Hampshire chapter of the American College of Nurse-Midwives.<br>&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp(d) One member from the New Hampshire section of the Association for Women's Health, Obstetric and Neonatal Nurses.<br>&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp(e) The administrator of maternal and child health who also is the Title V director, division of public health services, department of health and human services.<br>&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp(f) An epidemiologist from the department of health and human services with experience analyzing perinatal data, or designee.<br>&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp(g) A representative of the community mental health centers.<br>&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp(h) A public member.<br>&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp(i) The chief medical examiner, or designee.<br>&nbsp&nbsp&nbspII. Each member in subparagraphs I(a)-(h) shall be appointed by the commissioner of health and human services, or designee, in collaboration with the organizations listed in paragraph I.<br>&nbsp&nbsp&nbspIII. The term of each member shall be 3 years and the terms shall be staggered.  The chair shall be appointed by the commissioner.  The initially appointed chair shall call the meeting and panel together and shall serve as chair for 6 months, after which time, the panel shall elect its chair.  Members of the panel shall receive no compensation.<br>&nbsp&nbsp&nbspIV. The commissioner may delegate to the Northern New England Perinatal Quality Improvement Network (NNEPQIN) the functions of collecting, analyzing, and disseminating maternal mortality information, organizing and convening meetings of the panel, and other substantive and administrative tasks as may be incident to these activities.  The activities of NNEPQIN and its employees or agents shall be subject to the same confidentiality provisions as those that apply to the panel.<br>&nbsp&nbsp&nbspV. The commissioner shall submit an annual report beginning on June 1, 2011 to the oversight committee on health and human services describing adverse events reviewed by the panel, including statistics and causes, and outlining, in aggregate, corrective action plans, and making recommendations for system change and legislation relative to state health care operations.<br>&nbsp&nbsp&nbspVI. (a) The panel, in collaboration with the commissioner of the department of health and human services, or designee, shall conduct comprehensive multidisciplinary reviews of the maternal mortality deaths, as defined in RSA 132:29, I-III, in New Hampshire.<br>&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp(b) Each member of the panel shall be responsible for the dissemination of panel recommendations to his or her respective institutions and professional organizations.  All such information shall be disseminated through each participant's quality assurance program in order to protect the confidentiality of all participants and patients involved in any incident.<br>&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp(c) The panel shall not:<br>&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp(1) Call witnesses or take testimony from individuals involved in the investigation of a maternal death.<br>&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp(2) Enforce any public health standard or criminal law or otherwise participate in any legal proceeding, except if a member of the team is involved in the investigation of the death or resulting prosecution and must participate in a legal proceeding in the course of performing in his or her duties outside the team.<br>&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp(d) Proceedings, records, and opinions of the maternal mortality review panel are confidential, not subject to RSA 91-A, and not subject to discovery, subpoena, or introduction into evidence in any civil or criminal proceeding.  Nothing in this subparagraph shall be construed to limit or restrict the right to discover or use in any civil or criminal proceeding anything that is available from another source and entirely independent of the proceedings of the panel.<br>&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp(e) Members of the panel shall not be questioned in any civil or criminal proceeding regarding information presented in or opinions formed as a result of a meeting of the team.  Nothing in this subparagraph shall be construed to prevent a member of the panel from testifying to information obtained independently of the team or which is public information.<br>&nbsp&nbsp&nbspVII. The commissioner of the department of health and human services, with the advice and recommendation of a majority of members of the panel, shall adopt rules, pursuant to RSA 541-A, relative to the following:<br>&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp(a) The system for identifying and reporting maternal deaths to the commissioner, or designee.<br>&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp(b) The form and manner through which the program may acquire information under RSA 132:31.<br>&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp(c) The protocol to be used in carefully and sensitively contacting a family member of the deceased woman for a discussion of the events surrounding the death, allowing grieving family members to refuse such an interview.<br>&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp(d) Assuring de-identification of all individuals and facilities involved in the panel review of cases.">
</head>
<body>
<center><h1>TITLE X<br>PUBLIC HEALTH</h1></center>
<center><h2>CHAPTER 132<br>PROTECTION FOR MATERNITY AND INFANCY</h2></center>
<center><h2>Maternal Mortality Review Panel</h2></center>
<center><h3>Section 132:30</h3></center>
&nbsp;&nbsp;&nbsp;<b> 132:30 Maternal Mortality Review Panel Established. &#150;</b>
<codesect>
<br>
&nbsp&nbsp&nbsp
I. There is established a maternal mortality review panel to conduct comprehensive, multidisciplinary reviews of maternal deaths in New Hampshire for the purpose of identifying factors associated with the deaths and to make recommendations for system changes to improve services for women in the state.  The panel shall consist of:
<br>
&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp
(a) Two members from the New Hampshire chapter of the American College of Obstetricians and Gynecologists, one of whom shall be a generalist obstetrician, and one of whom shall be a maternal fetal medicine specialist.
<br>
&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp
(b) One member from the New Hampshire chapter of the American Academy of Pediatrics, specializing in neonatology.
<br>
&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp
(c) One member from the New Hampshire chapter of the American College of Nurse-Midwives.
<br>
&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp
(d) One member from the New Hampshire section of the Association for Women's Health, Obstetric and Neonatal Nurses.
<br>
&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp
(e) The administrator of maternal and child health who also is the Title V director, division of public health services, department of health and human services.
<br>
&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp
(f) An epidemiologist from the department of health and human services with experience analyzing perinatal data, or designee.
<br>
&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp
(g) A representative of the community mental health centers.
<br>
&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp
(h) A public member.
<br>
&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp
(i) The chief medical examiner, or designee.
<br>
&nbsp&nbsp&nbsp
II. Each member in subparagraphs I(a)-(h) shall be appointed by the commissioner of health and human services, or designee, in collaboration with the organizations listed in paragraph I.
<br>
&nbsp&nbsp&nbsp
III. The term of each member shall be 3 years and the terms shall be staggered.  The chair shall be appointed by the commissioner.  The initially appointed chair shall call the meeting and panel together and shall serve as chair for 6 months, after which time, the panel shall elect its chair.  Members of the panel shall receive no compensation.
<br>
&nbsp&nbsp&nbsp
IV. The commissioner may delegate to the Northern New England Perinatal Quality Improvement Network (NNEPQIN) the functions of collecting, analyzing, and disseminating maternal mortality information, organizing and convening meetings of the panel, and other substantive and administrative tasks as may be incident to these activities.  The activities of NNEPQIN and its employees or agents shall be subject to the same confidentiality provisions as those that apply to the panel.
<br>
&nbsp&nbsp&nbsp
V. The commissioner shall submit an annual report beginning on June 1, 2011 to the oversight committee on health and human services describing adverse events reviewed by the panel, including statistics and causes, and outlining, in aggregate, corrective action plans, and making recommendations for system change and legislation relative to state health care operations.
<br>
&nbsp&nbsp&nbsp
VI. (a) The panel, in collaboration with the commissioner of the department of health and human services, or designee, shall conduct comprehensive multidisciplinary reviews of the maternal mortality deaths, as defined in RSA 132:29, I-III, in New Hampshire.
<br>
&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp
(b) Each member of the panel shall be responsible for the dissemination of panel recommendations to his or her respective institutions and professional organizations.  All such information shall be disseminated through each participant's quality assurance program in order to protect the confidentiality of all participants and patients involved in any incident.
<br>
&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp
(c) The panel shall not:
<br>
&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp
(1) Call witnesses or take testimony from individuals involved in the investigation of a maternal death.
<br>
&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp
(2) Enforce any public health standard or criminal law or otherwise participate in any legal proceeding, except if a member of the team is involved in the investigation of the death or resulting prosecution and must participate in a legal proceeding in the course of performing in his or her duties outside the team.
<br>
&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp
(d) Proceedings, records, and opinions of the maternal mortality review panel are confidential, not subject to RSA 91-A, and not subject to discovery, subpoena, or introduction into evidence in any civil or criminal proceeding.  Nothing in this subparagraph shall be construed to limit or restrict the right to discover or use in any civil or criminal proceeding anything that is available from another source and entirely independent of the proceedings of the panel.
<br>
&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp
(e) Members of the panel shall not be questioned in any civil or criminal proceeding regarding information presented in or opinions formed as a result of a meeting of the team.  Nothing in this subparagraph shall be construed to prevent a member of the panel from testifying to information obtained independently of the team or which is public information.
<br>
&nbsp&nbsp&nbsp
VII. The commissioner of the department of health and human services, with the advice and recommendation of a majority of members of the panel, shall adopt rules, pursuant to RSA 541-A, relative to the following:
<br>
&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp
(a) The system for identifying and reporting maternal deaths to the commissioner, or designee.
<br>
&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp
(b) The form and manner through which the program may acquire information under RSA 132:31.
<br>
&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp
(c) The protocol to be used in carefully and sensitively contacting a family member of the deceased woman for a discussion of the events surrounding the death, allowing grieving family members to refuse such an interview.
<br>
&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp
(d) Assuring de-identification of all individuals and facilities involved in the panel review of cases.
</codesect>
<sourcenote>
<p><b>Source.</b>  2010, 129:2, eff. Aug. 8, 2010.</p>
</sourcenote>
</body>
</html>
